Jazz Pharmaceuticals PLC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
FMR LLC and Abigail P. Johnson have reported beneficial ownership of 7.4% of Jazz Pharmaceuticals PLC's common stock as of June 30, 2026.
NASDAQ
Vanguard Capital Management has reported beneficial ownership of over 3.1 million shares, representing 5.04% of Jazz Pharmaceuticals PLC's common stock.
NASDAQ
The Vanguard Group reports zero beneficial ownership in Jazz Pharmaceuticals PLC following an internal realignment.